Skip to content
Lower risk Medical device recall · FDA · Published August 14, 2023

Remel Todd Hewitt Broth Recall: Risk of False Negative Results in Bacterial Testing

Remel recalls Todd Hewitt Broth (lot 668255) used for Group B Strep testing due to potential false negatives in QC tests. Affected units may not detect target bacteria correctly.

🇺🇸 FDA recall #Z-2531-2023Medical deviceRemel ›
Take action

Contact the company

Recalling firmRemel, Inc12076 Santa Fe Trail Dr · Lenexa, KS 66215-3519
✎ GovInfoNow plain-language explainer

Remel is recalling a specific batch of Todd Hewitt Broth used to test for Group B Strep in clinical samples. This batch may fail to detect the target bacteria during quality checks, leading to incorrect test results. Read more at govinfonow.com/recall/57488-remel-todd-hewitt-broth-recall-risk-of-false-negative-results.

Source Summary by GovInfoNow · govinfonow.com/recall/57488-remel-todd-hewitt-broth-recall-risk-of-false-negative-results · Updated August 19, 2026 · FDA enforcement record: FDA #Z-2531-2023

Cite this page

“Remel Todd Hewitt Broth Recall: Risk of False Negative Results in Bacterial Testing.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/57488-remel-todd-hewitt-broth-recall-risk-of-false-negative-results. Based on FDA recall #Z-2531-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2531-2023%22&limit=1).

The FDA announced on August 14, 2023, that Remel, Inc. is recalling Todd Hewitt Broth with CNA (LIM) due to potential failure to recover target organisms. The agency issued recall number Z-2531-2023 for the Class II device.

How to tell if you have it

  • Brand: Remel
  • Product: TODD HEWITT W. CNA (LIM BROTH)
  • Reference: R064810
  • Lot code: 668255
  • Expiration date: 04/26/2024
  • UDI/DI: 00848838010064
  • Quantity: 139 units (13,900 tests)
  • Distribution: US Nationwide

The hazard

The recalled lot may exhibit no recovery of the target organism during customer quality control testing or use with patient samples. This issue affects the product's ability to isolate Group B Streptococci from clinical specimens containing mixed bacterial flora.

Context

GovInfoNow's records show Remel, Inc has issued 22 other recalls since November 2, 2017. Recent similar recalls include the Remel GC Agar Base Recall on June 3, 2026, and the Remel Yeastone Broth Recall on March 24, 2026. Other recent recalls of similar products include the Remel Neisseria meningitidis Gp C 2ml/VL recall (July 17, 2026), the Remel Oxoid Agglutinating Sera Recall (March 25, 2026), and the Quidel QuickVue Strep A Test Recall (April 6, 2026).

How to tell if you have this one

Check for the lot number 668255 on the packaging. The product is labeled as Todd Hewitt W. CNA (LIM) Broth with expiration date 04/26/2024.

  • Brand
    Remel
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Lot Number

    Look for lot number 668255 on the packaging to confirm if your product is affected.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide Distribution” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 37 days after the firm started it.

1. Firm started the recall: Aug 14, 202312. FDA classified it Class II: Sep 8, 202323. Published in FDA’s Enforcement Report: Sep 20, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is there a risk of serious injury from this product?

No, this is a laboratory product that does not pose a physical safety risk. The hazard is limited to inaccurate test results.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2531-2023 (August 14, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2531-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA